Company Valuation: DNA Investment

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 43,200 56,400 52,800
Change - 30.56% -6.38%
Enterprise Value (EV) 1 20,569 20,665 44,465
Change - 0.47% 115.17%
P/E 280x -79x 100x
PBR 0.36x 0.47x 0.44x
PEG - 0x -1x
Capitalization / Revenue 0.83x 1.2x 1.59x
EV / Revenue 0.39x 0.44x 1.34x
EV / EBITDA -9.49x 4.64x 23.2x
EV / EBIT -7.74x -579x -27.6x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 12.86 -59.47 43.89
Distribution rate - - -
Net sales 1 52,358 47,137 33,191
EBITDA 1 -2,169 4,458 1,921
EBIT 1 -2,658 -35.71 -1,612
Net income 1 154.4 -713.6 526.7
Net Debt 1 -22,631 -35,735 -8,335
Reference price 2 3,600.00 4,700.00 4,400.00
Nbr of stocks (in thousands) 12,000 12,000 12,000
Announcement Date 21/03/25 21/03/25 31/03/26
1VND in Million2VND
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 23.55L
17.03x3.05x11x4.4% 4.14TCr
25.47x3.87x16.55x1.31% 2.24TCr
14.15x1.91x10.5x6.37% 972.41Cr
13.78x1.6x9.11x4.1% 470.49Cr
14.12x1.63x9.7x10.44% 335.31Cr
18.71x0.9x6.85x1.97% 302.8Cr
32.8x4.04x21.99x - 272.48Cr
25.22x1.05x16.85x4.17% 167.75Cr
Average 20.16x 2.26x 12.82x 4.68% 988.49Cr
Weighted average by Cap. 19.25x 2.92x 12.50x 3.95%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. KSD Stock
  4. Valuation DNA Investment